Many patients experience headaches or migraine flares after increasing their GLP-1 dose. Learn how metabolic adaptation, appetite suppression, nausea, and dehydration may contribute.
GLP-1 medications reduce appetite, but the resulting changes in eating patterns and hydration may contribute to headaches and migraines in some patients. Learn the hidden connection.
Some patients report migraines after starting Ozempic, Wegovy, or Victoza. Learn how dehydration, appetite suppression, nausea, and metabolic changes may contribute to migraine attacks during GLP-1 therapy.
Headaches are a commonly overlooked side effect of GLP-1 medications. Learn how blood sugar changes, nausea, dehydration, and appetite suppression may contribute to head pain during treatment.
Nausea, vomiting, and digestive discomfort are among the most common GLP-1 side effects. Here’s why Ozempic and Victoza affect digestion differently — and why some patients tolerate one medication better than the other.
GLP-1 medications like Ozempic and Wegovy cause nausea through a powerful gut-brain interaction that changes digestion, fullness signaling, and appetite control. Here’s the science behind why semaglutide nausea feels so intense for some patients.
Some patients stop Ozempic and other weekly GLP-1 drugs despite improved blood sugar results. Persistent nausea, appetite suppression, treatment fatigue, and lifestyle burden may all contribute to long-term discontinuation.